Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01315249
Show Display Options
Rank Status Study
1 Completed
Has Results
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: indacaterol and glycopyrronium (QVA149);   Drug: Placebo to fluticasone/salmeterol;   Drug: fluticasone/salmeterol;   Drug: Placebo to indacaterol and glycopyrronium (QVA149)

Indicates status has not been verified in more than two years